&nbsp;

HCTFP_Policy_EN.pdf

Apr 2023

Document

HCTFP_Policy_Fr.pdf

Apr 2023

Programme de financement des traitements à coût élevé

Le Programme de financement des traitements à coût élevé finance principalement les médicaments anticancéreux injectables ou oraux onéreux...

Regimen

BELZ

Cancer Type:

Endocrine,

Pancreatic Neuroendocrine,

Genitourinary,

Renal cell / Kidney

Intent: Curative, Palliative

Funding:

Exceptional Access Program

Belzutifan – For the treatment of adult patients with von Hippel-Lindau (VHL) disease, based on criteria

Drugs Used:

belzutifan

Quick Link(s):

Regimen Monograph

Jun 2025

Regimen

DARODOCE

Cancer Type:

Genitourinary,

Prostate

Intent: Palliative

Funding:

Exceptional Access Program

darolutamide - For the treatment of patients with metastatic castration-sensitive prostate cancer (mCSPC) in combination with docetaxel

Drugs Used:

DOCEtaxel,

darolutamide

Quick Link(s):

Regimen Monograph

Mar 2024

Regimen

DARO(MNT)

Cancer Type:

Genitourinary,

Prostate

Intent: Palliative

Funding:

Exceptional Access Program

darolutamide - For the treatment of patients with metastatic castration-sensitive prostate cancer (mCSPC) in combination with docetaxel

Drugs Used:

darolutamide

Quick Link(s):

Regimen Monograph

Aug 2025

Regimen

DOXO(RT-W)

Cancer Type:

Endocrine,

Thyroid

Intent: Palliative

Drugs Used:

DOXOrubicin

Quick Link(s):

Regimen Monograph

Apr 2023

Regimen

DOCE(RT-W)

Cancer Type:

Head and Neck,

Squamous Cell

Intent: Adjuvant, Curative

Drugs Used:

DOCEtaxel

Quick Link(s):

Regimen Monograph

May 2023

Document

ConstipationAndDiarrheaWebinarPresentation-FR.pdf

Apr 2023

Document